Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Targeting CDC42 reduces skeletal degeneration after hematopoietic stem cell transplantation.

Autor: Landspersky T; School of Medicine, Department of internal Medicine III, Technical University of Munich, Munich, Germany., Stein M; Institute of Comparative Molecular Endocrinology, Ulm University, Ulm, Germany., Saçma M; Institute of Molecular Medicine, Stem Cells, and Aging, Ulm University, Ulm, Germany., Geuder J; Anthropology and Human Genomics, Faculty of Biology, Ludwig-Maximilians University, Munich, Germany., Braitsch K; School of Medicine, Department of internal Medicine III, Technical University of Munich, Munich, Germany., Rivière J; School of Medicine, Department of internal Medicine III, Technical University of Munich, Munich, Germany., Hettler F; School of Medicine, Department of internal Medicine III, Technical University of Munich, Munich, Germany., Romero Marquez S; School of Medicine, Department of internal Medicine III, Technical University of Munich, Munich, Germany., Vilne B; Bioinformatics Laboratory, Rīga Stradiņš University, Riga, Lettland., Hameister E; School of Medicine, Department of internal Medicine III, Technical University of Munich, Munich, Germany., Richter D; Institute of Comparative Molecular Endocrinology, Ulm University, Ulm, Germany., Schönhals E; School of Medicine, Department of internal Medicine III, Technical University of Munich, Munich, Germany., Tuckermann J; Institute of Comparative Molecular Endocrinology, Ulm University, Ulm, Germany., Verbeek M; School of Medicine, Department of internal Medicine III, Technical University of Munich, Munich, Germany., Herhaus P; School of Medicine, Department of internal Medicine III, Technical University of Munich, Munich, Germany., Hecker JS; School of Medicine, Department of internal Medicine III, Technical University of Munich, Munich, Germany., Bassermann F; School of Medicine, Department of internal Medicine III, Technical University of Munich, Munich, Germany., Götze KS; School of Medicine, Department of internal Medicine III, Technical University of Munich, Munich, Germany., Enard W; Anthropology and Human Genomics, Faculty of Biology, Ludwig-Maximilians University, Munich, Germany., Geiger H; Institute of Molecular Medicine, Stem Cells, and Aging, Ulm University, Ulm, Germany., Oostendorp RAJ; School of Medicine, Department of internal Medicine III, Technical University of Munich, Munich, Germany., Schreck C; School of Medicine, Department of internal Medicine III, Technical University of Munich, Munich, Germany.

Publikováno v: Blood advances [Blood Adv] 2024 Oct 22; Vol. 8 (20), pp. 5400-5414.

Osteoprogenitor SFRP1 prevents exhaustion of hematopoietic stem cells via PP2A-PR72/130-mediated regulation of p300.

Autor: Hettler F; Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology-Oncology, Munich., Schreck C; Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology-Oncology, Munich., Marquez SR; Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology-Oncology, Munich., Engleitner T; Technical University of Munich, School of Medicine, Center for Translational Cancer Research (TranslaTUM), 81675 Munich, Germany; Technical University of Munich, School of Medicine, Institute of Molecular Oncology and Functional Genomics, Munich., Vilne B; Bioinformatics Research Unit, Riga Stradins University, Riga, Latvia; netOmics, Riga., Landspersky T; Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology-Oncology, Munich., Weidner H; Bone Lab Dresden, Department of Medicine III and Center for Healthy Aging, Technische Universitaet Dresden, Dresden., Hausinger R; Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology-Oncology, Munich., Mishra R; Technical University of Munich, School of Medicine, Center for Translational Cancer Research (TranslaTUM), 81675 Munich, Germany; School of Medicine, Institute of Clinical Chemistry and Pathobiochemistry, Technical University of Munich, Munich., Oellinger R; Technical University of Munich, School of Medicine, Center for Translational Cancer Research (TranslaTUM), 81675 Munich, Germany; Technical University of Munich, School of Medicine, Institute of Molecular Oncology and Functional Genomics, Munich., Rauner M; Bone Lab Dresden, Department of Medicine III and Center for Healthy Aging, Technische Universitaet Dresden, Dresden., Naumann R; Max Planck Institute of Molecular Cell Biology and Genetics, Transgenic Core Facility., Peschel C; Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology/Oncology, 81675 Munich, Germany; German Cancer Consortium (DKTK), 69120 Heidelberg., Bassermann F; Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology/Oncology, 81675 Munich, Germany; German Cancer Consortium (DKTK), 69120 Heidelberg., Rad R; Technical University of Munich, School of Medicine, Center for Translational Cancer Research (TranslaTUM), 81675 Munich, Germany; Technical University of Munich, School of Medicine, Institute of Molecular Oncology and Functional Genomics, 81675 Munich, Germany; German Cancer Consortium (DKTK), 69120 Heidelberg., Istvanffy R; Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology/Oncology, 81675 Munich, Germany; Current address: Technical University of Munich, School of Medicine, Surgery Department, 81675 Munich., Oostendorp RAJ; Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology/Oncology, 81675 Munich. robert.oostendorp@tum.de.

Publikováno v: Haematologica [Haematologica] 2023 Feb 01; Vol. 108 (2), pp. 490-501. Date of Electronic Publication: 2023 Feb 01.

Autophagy in mesenchymal progenitors protects mice against bone marrow failure after severe intermittent stress.

Autor: Landspersky T; Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany., Saçma M; Institute of Molecular Medicine, Ulm University, Ulm, Germany., Rivière J; Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany., Hecker JS; Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany., Hettler F; Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany., Hameister E; TUM, School of Medicine, Clinical Chemistry and Pathobiochemistry, Munich, Germany., Brandstetter K; Human Biology and BioImaging, Faculty of Biology, Ludwig-Maximilians-Universität München, Munich, Germany., Istvánffy R; Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany., Romero Marquez S; Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany., Ludwig R; Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany., Götz M; Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany., Buck M; Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany., Wolf M; Institute of Experimental and Clinical Cell Therapy, Paracelsus University Salzburg, Salzburg, Austria., Schiemann M; TUM, Institute for Medical Microbiology, Immunology and Hygiene, CyTUM-MIH, Munich, Germany., Ruland J; TUM, School of Medicine, Clinical Chemistry and Pathobiochemistry, Munich, Germany., Strunk D; Institute of Experimental and Clinical Cell Therapy, Paracelsus University Salzburg, Salzburg, Austria., Shimamura A; Bone Marrow Failure and MDS Program, Dana Farber and Boston Children's Hospital, Boston, MA., Myers K; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH., Yamaguchi TP; Cancer and Developmental Biology Laboratory, Center for Cancer Research, National Cancer Institute-Frederick, National Institutes of Health, Frederick, MD., Kieslinger M; Department for Small Animals and Horses, University of Veterinary Medicine, Vienna, Austria; and., Leonhardt H; Human Biology and BioImaging, Faculty of Biology, Ludwig-Maximilians-Universität München, Munich, Germany., Bassermann F; Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Götze KS; Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Geiger H; Institute of Molecular Medicine, Ulm University, Ulm, Germany., Schreck C; Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany., Oostendorp RAJ; Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany.

Publikováno v: Blood [Blood] 2022 Feb 03; Vol. 139 (5), pp. 690-703.

Secreted factors from mouse embryonic fibroblasts maintain repopulating function of single cultured hematopoietic stem cells.

Autor: Romero Marquez S; Technical University of Munich, Klinikum rechts der Isar, Clinic and Polyclinic for Internal Medicine III, Munich, Germany; Technical University of Munich, Klinikum rechts der Isar, Department of Surgery, Munich., Hettler F; Technical University of Munich, Klinikum rechts der Isar, Clinic and Polyclinic for Internal Medicine III, Munich., Hausinger R; Technical University of Munich, Klinikum rechts der Isar, Clinic and Polyclinic for Internal Medicine III, Munich., Schreck C; Technical University of Munich, Klinikum rechts der Isar, Clinic and Polyclinic for Internal Medicine III, Munich., Landspersky T; Technical University of Munich, Klinikum rechts der Isar, Clinic and Polyclinic for Internal Medicine III, Munich., Henkel L; Technical University of Munich, Flow Cytometry Unit of the Technical University Munich, Institute for Medical Microbiology, Immunology and Hygiene (CyTUM-MIH), Munich., Angerpointner C; Technical University of Munich, Flow Cytometry Unit of the Technical University Munich, Institute for Medical Microbiology, Immunology and Hygiene (CyTUM-MIH), Munich., Demir IE; Technical University of Munich, Klinikum rechts der Isar, Department of Surgery, Munich., Schiemann M; Technical University of Munich, Flow Cytometry Unit of the Technical University Munich, Institute for Medical Microbiology, Immunology and Hygiene (CyTUM-MIH), Munich., Bassermann F; Technical University of Munich, Klinikum rechts der Isar, Clinic and Polyclinic for Internal Medicine III, Munich, Germany; German Cancer Consortium (DKTK), Heidelberg., Götze KS; Technical University of Munich, Klinikum rechts der Isar, Clinic and Polyclinic for Internal Medicine III, Munich, Germany; German Cancer Consortium (DKTK), Heidelberg., Istvánffy R; Technical University of Munich, Klinikum rechts der Isar, Clinic and Polyclinic for Internal Medicine III, Munich, Germany; Technical University of Munich, Klinikum rechts der Isar, Department of Surgery, Munich., Oostendorp RAJ; Technical University of Munich, Klinikum rechts der Isar, Clinic and Polyclinic for Internal Medicine III, Munich. robert.oostendorp@tum.de.

Publikováno v: Haematologica [Haematologica] 2021 Oct 01; Vol. 106 (10), pp. 2633-2640. Date of Electronic Publication: 2021 Oct 01.